The Slovak Republic – a new seat for the EMA

The European Medicines Agency, currently seated in London, will move to a new location within the European Union's territory, as the United Kingdom has notified the European Council under Article 50 of the Treaty on European Union of its intention to leave the Union.

The Slovak Republic has officially announced its candidacy for the EMA on 29 April 2017 by a letter of the Prime Minister of the Slovak Republic, Robert Fico, delivered to European Council President Donald Tusk and to the President of the European Commission, Jean-Claude Juncker.

By 31 July 2017, all interested Member States had the opportunity to submit their offer to host the EMA. The Slovak Republic reconfirmed its intention and presented a detailed offer that proved our readiness to host the EMA in Bratislava, the capital of the Slovak Republic.

This webpage provides you with all the necessary information about the candidacy of the Slovak Republic to host the EMA.